North China Pharmaceutical Company.Ltd (SHA:600812)

SHA:600812 Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 2, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	9,505	8,870	9,780	10,981	20,452	16,781
Market Cap Growth	-0.54%	-9.30%	-10.94%	-46.31%	21.87%	4.57%
Enterprise Value	20,205	19,926	20,598	20,895	30,116	25,631
Last Close Price	5.54	5.15	5.66	6.36	11.73	10.10
PE Ratio	52.29	69.85	1999.79	-	1092.06	172.42
Forward PE	-	40.53	40.53	40.53	40.53	40.53
PS Ratio	0.97	0.90	0.97	1.05	1.97	1.46
PB Ratio	1.42	1.33	1.56	1.76	2.91	2.38
P/TBV Ratio	3.58	3.37	2.93	3.01	4.32	3.44
P/FCF Ratio	63.25	19.92	24.37	24.14	40.68	-
P/OCF Ratio	11.42	7.21	9.55	10.93	19.47	22.31
EV/Sales Ratio	2.06	2.02	2.04	1.99	2.90	2.23
EV/EBITDA Ratio	13.13	13.64	16.15	15.51	24.60	21.04
EV/EBIT Ratio	31.43	29.61	38.40	32.92	50.18	42.87
EV/FCF Ratio	134.46	44.74	51.34	45.94	59.90	-
Debt / Equity Ratio	1.67	1.72	1.78	1.77	1.96	1.62
Debt / EBITDA Ratio	7.24	7.47	7.88	7.81	10.57	9.40
Debt / FCF Ratio	74.11	25.71	27.78	24.29	27.40	-
Asset Turnover	0.45	0.47	0.48	0.46	0.43	0.54
Inventory Turnover	2.87	2.63	2.69	2.87	2.76	3.17
Quick Ratio	0.47	0.50	0.49	0.49	0.70	0.80
Current Ratio	0.67	0.75	0.78	0.72	0.89	1.03
Return on Equity (ROE)	4.22%	3.32%	0.79%	-10.25%	0.50%	1.63%
Return on Assets (ROA)	1.86%	1.98%	1.59%	1.72%	1.54%	1.74%
Return on Invested Capital (ROIC)	2.99%	2.84%	1.04%	4.08%	1.08%	2.44%
Return on Capital Employed (ROCE)	7.00%	6.40%	5.00%	7.20%	5.60%	4.90%
Earnings Yield	1.93%	1.43%	0.05%	-6.28%	0.09%	0.58%
FCF Yield	1.58%	5.02%	4.10%	4.14%	2.46%	-1.52%
Dividend Yield	0.53%	0.58%	0.18%	-	0.51%	0.30%
Payout Ratio	241.49%	369.37%	10195.21%	-	3987.68%	674.90%
Buyback Yield / Dilution	-7.99%	-5.27%	4.92%	-0.70%	-4.96%	0.12%
Total Shareholder Return	-7.46%	-4.69%	5.10%	-0.70%	-4.45%	0.42%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.